相关实验视频
Updated: Mar 1, 2026

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.7K
估计和双重可靠的估计对集群随机试验与生存结果
Xi Fang1,2, Bingkai Wang3, Liangyuan Hu4
1Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.
Statistics in medicine
|February 28, 2026
概括
这项研究引入了新的统计方法,用于分析集群随机试验 (CRT) 与生存数据. 两倍强大的估计器准确地估计了集群和个人层面的治疗效应,即使是复杂的审查.
科学领域:
- 生物统计学 生物统计学
- 流行病学 流行病学
- 临床试验 临床试验
背景情况:
- 集群随机试验 (CRT) 涉及随机分组,需要专门的分析.
- 在CRT中估计治疗效应需要区分集群级和个人级影响.
- 在CRT中生存结果带来了独特的分析挑战,特别是在正确的审查中.
研究的目的:
- 为了正式定义集群级别和个人级别的治疗效果估计,对CRT与右审查的生存数据.
- 为这些估计提出新的,双重可靠的估计器.
- 提供可靠的统计方法来分析CRT中的生存结果.
主要方法:
- 开发了对集群和个人水平治疗效应的双倍可靠的估计器.
- 针对基线共变量的依赖性审查,确保结果或审查模型正确时的一致性.
- 采用各种模拟策略进行审查和结果分配.
- 使用基于删除的刀方法来估计差异和间隔.
主要成果:
- 建议的估计器在依赖性审查下显示出一致性.
- 模拟研究证实了这些方法的有限样本性能充足.
- 这些方法已经成功地应用于现实世界的CRT,具有生存终点.
结论:
- 开发的两倍强大的估计器为分析CRT生存数据提供了可靠的方法.
- 这些方法通过在不同水平上准确区分治疗效应来增强因果推断.
- 这些发现为研究人员进行具有生存结果的CRT提供了有价值的工具.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
674
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
674
Assumptions of Survival Analysis
467
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
467
Kaplan-Meier Approach
663
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
663
Parametric Survival Analysis: Weibull and Exponential Methods
1.2K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.2K
Survival Tree
451
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
451
Cancer Survival Analysis
805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805

